CoChat

Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study

Open access
Huth, Cornelia, von Toerne, Christine, Schederecker, Florian, de las Heras Gala, Tonia, Herder, Christian, Kronenberg, Florian, Meisinger, Christa, Rathmann, Wolfgang, Koenig, Wolfgang, Waldenberger, Melanie, Roden, Michael, Peters, Annette, Hauck, Stefanie M., Thorand, Barbara · 2019 · European Journal of Epidemiology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German KORA F4/FF4 study (6.5-year follow-up). 892 participants aged 42-81 years were selected using a case-cohort design, including 123 persons with incident type 2 diabetes and 255 persons with incident WHO-defined prediabetes. Prospective associations between protein levels and diabetes, prediabetes as well as continuous fasting and 2 h glucose, fasting insulin and insulin resistance were investigated using regression models adjusted for established risk factors. The best predictive panel of proteins on top of a non-invasive risk factor model or on top of HbA1c, age, and sex was selected. Mannan-binding lectin serine peptidase (MASP) levels were positively associated with both incident type 2 diabetes and prediabetes. Adiponectin was inversely associated with incident type 2 diabetes. MASP, adiponectin, apolipoprotein A-IV, apolipoprotein C-II, C-reactive protein, and glycosylphosphatidylinositol specific phospholipase D1 were associated with individual continuous outcomes. The combination of MASP, apolipoprotein E (apoE) and adiponectin improved diabetes prediction on top of both reference models, while prediabetes prediction was improved by MASP plus CRP on top of the HbA1c model. In conclusion, our mass spectrometric approach revealed a novel association of MASP with incident type 2 diabetes and incident prediabetes. In combination, MASP, adiponectin and apoE improved type 2 diabetes prediction beyond non-invasive risk factors or HbA1c, age and sex.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10654-018-0475-8

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flowchart showing sample sizes and reasons for exclusions
Fig. 1 Flowchart showing sample sizes and reasons for exclusionsCC BY · PubMed Central
Fig. 2 ORs with 95% CIs for incident type 2 diabetes per one sex-specific SD increase in SRM-MS measured proteins (n = 783), adjusted for age, sex, waist circumference, height, smoking, physical inactivity, actual hypertension, triglyceride level, and total cholesterol/HDL-cholesterol ratio (model 2a). Bars and diamonds of proteins associated statistically significantly with incident type 2 diabetes are printed in bold. apoA-IV apolipoprotein A-IV; apoC-II apolipoprotein C-II; apoC-III apolipoprotein C-III; apoE apolipoprotein E; CD5L CD5 molecule-like; CRP C-reactive protein; GPLD1 glycosylphosphatidylinositol-specific phospholipase D1; MASP mannan-binding lectin serine peptidase; MBL2 mannose-binding lectin 2; PZP pregnancy-zone protein; RBP4 retinol-binding protein 4; SHBG sex hormone-binding globulin; THBS1 thrombospondin 1
Fig. 2 ORs with 95% CIs for incident type 2 diabetes per one sex-specific SD increase in SRM-MS measured proteins (n = 783), adjusted for age, sex, waist circumference, height, smoking, physical inactivity, actual hypertension, triglyceride level, and total cholesterol/HDL-cholesterol ratio (model 2a). Bars and diamonds of proteins associated statistically significantly with incident type 2 diabetes are printed in bold. apoA-IV apolipoprotein A-IV; apoC-II apolipoprotein C-II; apoC-III apolipoprotein C-III; apoE apolipoprotein E; CD5L CD5 molecule-like; CRP C-reactive protein; GPLD1 glycosylphosphatidylinositol-specific phospholipase D1; MASP mannan-binding lectin serine peptidase; MBL2 mannose-binding lectin 2; PZP pregnancy-zone protein; RBP4 retinol-binding protein 4; SHBG sex hormone-binding globulin; THBS1 thrombospondin 1CC BY · PubMed Central
Fig. 3 Estimated difference in continuous outcomes at follow-up for study participants not taking glucose-lowering medication expressed as the SD change in the continuous outcome (standardized z-score β estimate with 95% CI) per one sex-specific SD increase in the respective protein, adjusted for age, sex, waist circumference, height, smoking, physical inactivity, actual hypertension, triglyceride level, total cholesterol/HDL-cholesterol ratio (model 2a) and the baseline value of the investigated outcome variable. FG fasting glucose (n = 855); 2hG 2-h-glucose (n = 831); FI fasting insulin (n = 851), IR HOMA-insulin resistance (n = 851). Bars and diamonds of proteins associated statistically significantly are printed in bold. apoA-IV apolipoprotein A-IV; apoC-II apolipoprotein C-II; apoC-III apolipoprotein C-III; apoE apolipoprotein E; CD5L CD5 molecule-like; CRP C-reactive protein; GPLD1 glycosylphosphatidylinositol-specific phospholipase D1; MASP mannan-binding lectin serine peptidase; MBL2 mannose-binding lectin 2; PZP pregnancy-zone protein; RBP4 retinol-binding protein 4; SHBG sex hormone-binding globulin; THBS1 thrombospondin 1
Fig. 3 Estimated difference in continuous outcomes at follow-up for study participants not taking glucose-lowering medication expressed as the SD change in the continuous outcome (standardized z-score β estimate with 95% CI) per one sex-specific SD increase in the respective protein, adjusted for age, sex, waist circumference, height, smoking, physical inactivity, actual hypertension, triglyceride level, total cholesterol/HDL-cholesterol ratio (model 2a) and the baseline value of the investigated outcome variable. FG fasting glucose (n = 855); 2hG 2-h-glucose (n = 831); FI fasting insulin (n = 851), IR HOMA-insulin resistance (n = 851). Bars and diamonds of proteins associated statistically significantly are printed in bold. apoA-IV apolipoprotein A-IV; apoC-II apolipoprotein C-II; apoC-III apolipoprotein C-III; apoE apolipoprotein E; CD5L CD5 molecule-like; CRP C-reactive protein; GPLD1 glycosylphosphatidylinositol-specific phospholipase D1; MASP mannan-binding lectin serine peptidase; MBL2 mannose-binding lectin 2; PZP pregnancy-zone protein; RBP4 retinol-binding protein 4; SHBG sex hormone-binding globulin; THBS1 thrombospondin 1CC BY · PubMed Central
Fig. 4 a Receiver operating characteristic (ROC) curves comparing main prediction models for incident type 2 diabetes. b Risk assessment plot for the GDRSadapted prediction model, without (dashed lines) and with (solid lines) protein-extension. Lines in the lower left part of the figure represent 1-specificity for all possible risk cut-offs for non-cases; lines in the upper right part represent sensitivity for type 2 diabetes cases. The grey area represents the integrated discrimination improvement (IDI). c Risk assessment plot for the ‘Age + Sex + HbA1c’ prediction model, without (dashed lines) and with (solid lines) protein-extension. The non-case data was grossed up to represent the complete study cohort for the parts B and C of this figure in order to illustrate the relationship between risk of type 2 diabetes, sensitivity and specificity correctly. The ROC- and risk assessment plots were drawn using the complete study data without bootstrapping. Therefore, the AUC values displayed here deviate from the AUCbootstrap values given in the text. All basic, extended and DeltaAUC values computed based on the complete study data are supplied in the Supplemental Table 4
Fig. 4 a Receiver operating characteristic (ROC) curves comparing main prediction models for incident type 2 diabetes. b Risk assessment plot for the GDRSadapted prediction model, without (dashed lines) and with (solid lines) protein-extension. Lines in the lower left part of the figure represent 1-specificity for all possible risk cut-offs for non-cases; lines in the upper right part represent sensitivity for type 2 diabetes cases. The grey area represents the integrated discrimination improvement (IDI). c Risk assessment plot for the ‘Age + Sex + HbA1c’ prediction model, without (dashed lines) and with (solid lines) protein-extension. The non-case data was grossed up to represent the complete study cohort for the parts B and C of this figure in order to illustrate the relationship between risk of type 2 diabetes, sensitivity and specificity correctly. The ROC- and risk assessment plots were drawn using the complete study data without bootstrapping. Therefore, the AUC values displayed here deviate from the AUCbootstrap values given in the text. All basic, extended and DeltaAUC values computed based on the complete study data are supplied in the Supplemental Table 4CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. WHO. Global report on diabetes. Geneva, Switzerland: WHO Press; 2006.

Cited by

See all 57

Metadata

Authors
Huth, C., von Toerne, C., Schederecker, F., de las Heras Gala, T., Herder, C., Kronenberg, F., Meisinger, C., Rathmann, W., Koenig, W., Waldenberger, M., Roden, M., Peters, A., Hauck, S. M., & Thorand, B.
Affiliations
  • Helmholtz Munich (DE)
  • Deutsches Diabetes-Zentrum e.V. (DE)
  • Innsbruck Medical University (AT)
Corresponding author
Huth, Cornelia
Venue
European Journal of Epidemiology
Published
2018-12-31
Volume
34
Issue
4
Pages
409-422
ISSN
  • 0393-2990 (ISSN-L)
  • 1573-7284
OpenAlex
W2907303285
Cited by
56
References
44
Citations by year
2026: 3 · 2025: 8 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 14 · 2020: 12 · 2019: 1 · 2018: 1
FWCI
5.66
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • European Journal of Epidemiology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Site cant be reached (submittedVersion, other-oa)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
  • OPUS (Augsburg University) (submittedVersion, cc-by)
Funders
  • Bundesministerium für Bildung und Forschung
  • Ministerium für Wissenschaft und Forschung Nordrhein-Westfalen
  • Bundesministerium für Gesundheit
  • Bundesland Bayern
  • Munich Center of Health Sciences
  • Deutsche Forschungsgemeinschaft (DFG, RA 459/2-1)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
type 2 diabetes, prediabetes, plasma protein biomarkers, adiponectin, apolipoprotein E, C-reactive protein, apolipoprotein A-IV, apolipoprotein C-II, diabetes risk prediction, insulin resistance, HbA1c
MeSH terms
Adult, Aged, Aged, 80 and over, Apolipoproteins E, Diabetes Mellitus, Type 2, Female, Germany, Humans, Male, Middle Aged, Prediabetic State, Prospective Studies, Risk Factors, Biomarkers, Proteomics, Mannose-Binding Protein-Associated Serine Proteases, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study. https://app.cochat.ai/papers/10.1007/s10654-018-0475-8
The paper
Huth, C., von Toerne, C., Schederecker, F., de las Heras Gala, T., Herder, C., Kronenberg, F., Meisinger, C., Rathmann, W., Koenig, W., Waldenberger, M., Roden, M., Peters, A., Hauck, S. M., & Thorand, B. (2019). Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study. European Journal of Epidemiology. https://doi.org/10.1007/s10654-018-0475-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.